Company profile · Onderzoeks- & kennisinstelling
COSMIC: Combatting Disorders of Adaptive Immunity with Systems Medicine
- Research
- Onderzoeks- & kennisinstelling
- Amsterdam
- Research · Amsterdam
- Founded
- 2017
- Province
- Noord-Holland
- Country
- Netherlands
About COSMIC: Combatting Disorders of Adaptive Immunity with Systems Medicine
COSMIC: Combatting Disorders of Adaptive Immunity with Systems Medicine
The Marie Skłodowska-Curie actions (MSCA) support researchers at all stages of their careers. One type of action is the European Training Network (ETN) aimed at joint research training by partners from academia, industry, and other organisation. COSMIC is a ETN funded from the European Union's Horizon 2020 research and innovation programme under grant agreement No 765158.
COSMIC delivers the next generation of systems medicine professionals who successfully combat complex human disorders. We will focus on B-cell lymphoma and rheumatoid arthritis, diseases that originate from abnormal functioning of the adaptive immune system, in particular the germinal center. COSMIC develops and integrates experimental and computational approaches, and establish a unique cross-fertilization between oncology and auto-immunity.
Keywords
- Adaptive Immunity
- B-Cell Lymphoma
- Computational Modelling
- Rheumatoid Arthritis
- Systems Medicine
Address
Headquarters
Meibergdreef 91105AZ AmsterdamNoord-Holland, Netherlands
Team by function
Based on 1 public job profiles as of 5 September 2026.
- Operations1
Similar companies
Companies with a similar profile, Noord-Holland first.

European Sepsis Academy
Research · Amsterdam
11–50 employeesView profile

Amsterdam Rheumatology Center for AutoImmune Diseases
Research · Amsterdam
11–50 employeesView profile

Immunotherapy Center Amsterdam UMC
Biotechnology · Amsterdam
11–50 employeesView profile

AMIOS - Amsterdam Multidisciplinary Interventional Oncology Symposium
Medical Practice · Amsterdam
201–500 employeesView profile

Amsterdam UMC - Amsterdam institute for Immunology and Infectious Diseases
Research · Amsterdam
201–500 employeesView profile

EATRIS
Research · Amsterdam
51–200 employeesView profile